,60, 61, 62 Recent studies revealed that MS patients with limited presence of CD20+ B cells and CD138+ plasma cells in white matter tissue show reduced intrathecal IgG production, based on IgG CSF/plasma ratios and OCB profiles, and have less severe clinical outcomes.18 The gene discussed is SDC1; the disease is myeloid sarcoma.